DOOH:
804
Seggel, MR; Yousif, MY; Lyon, RA; Titeler, M; Roth, BL; Suba, EA; Glennon, RA. A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors J. Med. Chem., 1 Mar 1990, 33 (3), 1032–1036. 807 kB. https://doi.org/10.1021/jm00165a023 #1z
Foster, BC; McLeish, J; Wilson, DL; Whitehouse, LW; Zamecnik, J; Lodge, BA. Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata Xenobiotica, 1 Jan 1992, 22 (12), 1383–1394. 765 kB. https://doi.org/10.3109/00498259209056689 #1m MS,NMR
Runyon, SP; Mosier, PD; Roth, BL; Glennon, RA; Westkaemper, RB. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: A ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation J. Med. Chem., 13 Nov 2008, 51 (21), 6808–6828. 2.2 MB. https://doi.org/10.1021/jm800771x #2g NMR
Anderson, GM; Castagnoli, N; Kollman, PA. Quantitative structure-activity relationships in the 2,4,5-ring-substituted phenylisopropylamines In QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. NIDA Research Monograph 22; Barnett, G; Trsic, M; Willette, RE, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1978; pp 199–217. 623 kB. #21
Glennon, RA; Seggel, MR. Interaction of phenylisopropylamines with central 5-HT2 receptors. Analysis by quantitative structure-activity relationships In Probing Bioactive Mechanisms; ACS Symposium Series; Magee, PS; Henry, DR; Block, JH, Eds., American Chemical Society, Washington, DC, 14 Nov 1989; Vol. 413, pp 264–280. 4.4 MB. https://doi.org/10.1021/bk-1989-0413.ch018 #26
2,5-Dimethoxy-β-hydroxy-4-methylphenethylamine · BOHD
4-D · 4-Trideuteromescaline
β,β-Dideuteromescaline · β-D
2,3,4-Trimethoxyphenethylamine · IM · Isomescaline
2,4,6-TMPEA · 2C-TMA-6 · TMPEA-6 · ψ-2C-O
3,5-D · 3,5-Di(trideutero)mescaline
2,6-D · 2,6-Dideuteromescaline
α,α-Dideuteromescaline · α-D
3-Hydroxy-4,5-dimethoxy-N-methylphenethylamine · N-Me-3-DESMETHYL
β-HO-2,5-DMA · β-Hydroxy-2,5-dimethoxyamphetamine
N-Isopropyl-β,3,4-trihydroxyphenethylamine · β,3,4-HO-N-iPr-DHPEA
N-Methyl-N,4-dihydroxy-3-methoxyamphetamine · MHMAOH
N,N-Dimethyl-β,3-dihydroxy-4-methoxyphenethylamine · N,N-Me-HME
N-Me-DME · Normacromerine
β,3,4-TMPEA · β,3,4-Trimethoxyphenethylamine
N-Hydroxy-3,4-dimethoxyamphetamine · DMAOH · HOT-DMA
β-HO-DMA · β-Hydroxy-3,4-dimethoxyamphetamine
β-HO-4,3-EMPEA · β-Hydroxy-4-ethoxy-3-methoxyamphetamine
β,2-Dihydroxy-5-methoxymethamphetamine · β,2-HO-N-Me-5-MA
β-HO-N-Me-2,5-DMPEA · β-Hydroxy-N-methyl-2,5-dimethoxyphenethylamine
BODM · β,2,5-Trimethoxyphenethylamine · β-HO-2C-H
β-HO,Me-2,5-DMPEA · β-Hydroxy-β-methyl-2,5-dimethoxyphenethylamine
β,2-Dihydroxy-N-methyl-5-ethoxyphenethylamine · β,2-HO-N-Me-5-EPEA
β,2-Dihydroxy-5-ethoxyamphetamine · β,2-HO-5-EA
β-HO-N-Me-3,5-DMPEA · β-Hydroxy-N-methyl-3,5-dimethoxyphenethylamine
β-HO-N-Me-2,6-DMPEA · β-Hydroxy-N-methyl-2,6-dimethoxyphenethylamine
2,3,5-Trimethoxyphenethylamine · TMPEA-4
N-HO-2C-D · N-Hydroxy-4-methyl-2,5-dimethoxyphenethylamine
3-Hydroxy-4,5-dimethoxyamphetamine · α-Me-3-DESMETHYL
N-Methyl-4-hydroxy-3,5-dimethoxyphenethylamine · DESMETHYL-M
4-Hydroxy-3,5-dimethoxyamphetamine · α-Me-DESMETHYL
N-Isopropyl-β,2,3-trihydroxyphenethylamine · N-iPr-β-HO-2,3-HPEA
N-Isopropyl-β,3,5-trihydroxyphenethylamine · N-iPr-β-HO-3,5-HPEA
N-Methyl-3,4,5-trimethoxybenzylamine
α,β-D · α,β-Dideutero-3,4,5-trimethoxyphenethylamine · α,β-Dideuteromescaline
5-DM-TMA-2 · 5-Hydroxy-2,4-dimethoxyamphetamine
2-DM-TMA-2 · 2-Hydroxy-4,5-dimethoxyamphetamine